Lincoln Property, Intercontinental Kickstart Life Science Project

222 Fifth. Image courtesy of Gensler

LPC West is adding another life science project to its Seattle portfolio through its nine-story development with Intercontinental Real Estate Corp. The partners broke ground on 222 Fifth and are expecting to complete the project in early 2024.

The 197,000-square-foot life science development will be purpose built for research use, offering outside air exchange, dedicated emergency power, side-loaded floors designed for lab layouts, ample ceiling heights and a loading dock specifically made for lab use. The developers are also incorporating on-site security, a coffee shop, evening bar and a 10,000-square-foot outdoor viewing deck.

J.P. Harlow, senior vice president at LPC West, said in prepared remarks that 222 Fifth will have specifications and amenities for life science uses that exceed other similar facilities in the city. LPC West and Intercontinental tapped Gensler to design the building, while CBRE will be the project’s leasing advisor.

READ ALSO: Adaptive Reuse or New Construction? Considerations for Life Sciences

Once completed, 222 Fifth will be the anchor for the South Lake Union Innovation District, which stretches a third of a city block in downtown Seattle. The mixed-use district calls for residential and retail space and has several projects already underway. One of the projects, SiteLine Luxury Apartments, will include 181 luxury apartments, 43 affordable units and 50,000 square feet of retail space when completed in 2023.

Building out Seattle’s life science hub

Along with 222 Fifth, LPC West is working on another life science project in Seattle. In a partnership with Invesco Real Estate, the company is converting The Cascadian, a recently built nine-story office building, into a life science facility. LPC West and Invesco acquired the property from a joint venture between Unico Properties and Partners Group, which completed the development in 2021.

Beyond Seattle, LPC West also owns and operates more than 5.5 million square feet of life science facilities on the West Coast. Previously, the company and its joint venture partner Angelo Gordon acquired a 240,904-square-foot office campus in Pasadena, Calif., that is also being renovated with lab spaces.